HomeQLGN • NASDAQ
add
Qualigen Therapeutics Inc
Previous close
$1.90
Day range
$1.76 - $1.95
Year range
$1.76 - $11.50
Market cap
2.88M USD
Avg Volume
1.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.49M | 135.92% |
Net income | -2.65M | -30.18% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.21K | -67.59% |
Total assets | 2.85M | 183.84% |
Total liabilities | 2.81M | -37.80% |
Total equity | 33.13K | — |
Shares outstanding | 1.64M | — |
Price to book | -1.10 | — |
Return on assets | -167.75% | — |
Return on capital | -355.43% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.65M | -30.18% |
Cash from operations | -1.59M | -102.84% |
Cash from investing | -305.00K | — |
Cash from financing | 750.00K | 57.89% |
Net change in cash | -1.14M | -270.85% |
Free cash flow | -967.66K | -231.14% |
About
Founded
1996
Headquarters
Website
Employees
4
